Filing Details
- Accession Number:
- 0001493152-22-026823
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-26 17:00:09
- Reporting Period:
- 2022-09-22
- Accepted Time:
- 2022-09-26 17:00:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
714256 | Sanara Medtech Inc. | SMTI | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 592220004 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1799604 | M. Shawn Bowman | 1200 Summit Ave Suite 414 Fort Worth TX 76102 | Pres. - Strategic Partnerships | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-09-22 | 660 | $27.54 | 18,890 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-09-22 | 340 | $28.56 | 18,550 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2022.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.185 to $28.10, inclusive. The reporting person undertakes to provide to Sanara MedTech Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.20 to $29.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.